Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Junlong Zhu
Observed names:
ZHU Junlong,
Zhu, Junlong
Institutions:
The Affiliated Yongchuan Hospital of Chongqing Medical University,
Southwest Hospital,
Chengdu University of Traditional Chinese Medicine
Observed institutions:
Hangzhou Normal University,
The Affiliated Yongchuan Hospital of Chongqing Medical University,
Southwest Hospital,
Chengdu University of Traditional Chinese Medicine,
Chongqing Medical University
ORCID:
0009-0009-1189-2829
Observed ORCIDs:
0009-0009-1189-2829,
0000-0002-9389-8256
OpenAlex ID:
A5038375800
Anti-Tumor Drug Discovery Based on Natural Product β-Elemene: Anti-Tumor Mechanisms and Structural Modification
2021
·
Ziqiang Bai
, Chuansheng Yao
, et al.
·
Molecules
·
114
PDF
Combination of chemotherapy and gaseous signaling molecular therapy: Novel β‐elemene nitric oxide donor derivatives against leukemia
2023
·
Junlong Zhu
, Xiaoying Jiang
, et al.
·
Drug Development Research
·
101
Discovery of plant-derived anti-tumor natural products: Potential leads for anti-tumor drug discovery
2023
·
Zi Hui
, Hao Wen
, et al.
·
Bioorganic Chemistry
·
98
Second generation β-elemene nitric oxide derivatives with reasonable linkers: potential hybrids against malignant brain glioma
2022
·
Renren Bai
, Junlong Zhu
, et al.
·
Journal of Enzyme Inhibition and Medicinal Chemistry
·
65
Click chemistry-aided drug discovery: A retrospective and prospective outlook
2023
·
Rui Zhao
, Junlong Zhu
, et al.
·
European Journal of Medicinal Chemistry
·
48
Starvation induced autophagy promotes the progression of bladder cancer by LDHA mediated metabolic reprogramming
2021
·
Tinghao Li
, Hang Tong
, et al.
·
Cancer Cell International
·
45
YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1–RPN2–PI3K/AKT/mTOR Axis
2023
·
Junlong Zhu
, Hang Tong
, et al.
·
International Journal of Molecular Sciences
·
44
PDF
SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis
2021
·
Zijia Qin
, Hang Tong
, et al.
·
International Journal of Molecular Medicine
·
35
PDF
HDAC1/MAO-B dual inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation of N-propargylamine-hydroxamic acid/o-aminobenzamide hybrids
2022
·
Chuansheng Yao
, Xiaoying Jiang
, et al.
·
Bioorganic Chemistry
·
33
A Glycolysis-Based Long Non-coding RNA Signature Accurately Predicts Prognosis in Renal Carcinoma Patients
2021
·
Honghao Cao
, Hang Tong
, et al.
·
Frontiers in Genetics
·
28
PDF
SIRT1 Promotes Cisplatin Resistance in Bladder Cancer via Beclin1 Deacetylation-Mediated Autophagy
2023
·
Yan Sun
, Xudong Liu
, et al.
·
Cancers
·
27
PDF
Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer
2025
·
Tinghao Li
, Kunyao Zhu
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
26
Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification
2022
·
Zhichao Zhong
, Xingrui He
, et al.
·
European Journal of Medicinal Chemistry
·
23
miR-29a-5p modulates ferroptosis by targeting ferritin heavy chain FTH1 in prostate cancer
2023
·
Guang Yang
, Qi Pan
, et al.
·
Biochemical and Biophysical Research Communications
·
17
Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma
2022
·
Tinghao Li
, Hang Tong
, et al.
·
Frontiers in Medicine
·
17
Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer
2023
·
Meng Zhang
, Junlong Zhu
, et al.
·
Frontiers in Oncology
·
14
Nucleolar protein 3 promotes proliferation of bladder cancer cells through the PI3K-Akt pathway
2024
·
Linfeng Wu
, Kunyao Zhu
, et al.
·
World Journal of Surgical Oncology
·
11
PDF
PP2A promotes apoptosis and facilitates docetaxel sensitivity via the PP2A/p‑eIF4B/XIAP signaling pathway in prostate cancer
2022
·
Siwen Yin
, Yong Chen
, et al.
·
Oncology Letters
·
11
PDF
Integrative multi-omics and single-cell transcriptomics reveal ARHGEF12 driving chemoresistance in bladder cancer
2025
·
Kunyao Zhu
, Zhejiao Zhang
, et al.
·
Hereditas
·
3
PDF
Ursolic acid sensitizes bladder cancer to gemcitabine chemotherapy by concurrently targeting PI3K/AKT and JNK pathways
2025
·
Xiaolong Huang
, Yan Sun
, et al.
·
Translational Andrology and Urology
·
3
lncRNA DLGAP1-AS2 Modulates the TGF-β/Smad Signaling Pathway to Regulate Epithelial-Mesenchymal Transition in Renal Cell Carcinoma
2026
·
Honghao Cao
, Junlong Zhu
, et al.
·
Biochemical Genetics
·
2
RBM11 drives malignant progression of bladder cancer by regulating GNPDA1-PKM2 axis
2026
·
Hang Tong
, Tinghao Li
, et al.
·
iScience
·
2
Unraveling the mechanism of tetracycline-induced renal injury: an evaluation of drug safety based on network toxicology and molecular dynamics simulations
2025
·
Yimao Wu
, Yalun Liang
, et al.
·
BMC Pharmacology and Toxicology
·
2
Single-cell transcriptome analysis reveals DNMT1+ epithelial cells promote lymphatic metastasis via CXCL17-mediated TAM infiltration
2026
·
Guo Yang
, Jiayu Liu
, et al.
·
Journal of Translational Medicine
·
1
Ursolic acid enhances gemcitabine - induced apoptosis in bladder cancer via the PI3K/AKT and JNK signaling pathways
2022
·
Xiaolong Huang
, Yan Sun
, et al.
·
Research Square
·
1
Show more works
View as search
Works count:
36
Citation count:
773
H-index:
15
I10-index:
18
Year
Topic
Type